Publicaciones en las que colabora con JOSÉ TOMÁS RAMOS AMADOR (10)

2007

  1. Prevalencia de resistencia a fármacos antirretrovirales en España

    Anales de Pediatria, Vol. 67, Núm. 2, pp. 104-108

2006

  1. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

    BMC Infectious Diseases, Vol. 6

  2. Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy

    BMC Infectious Diseases, Vol. 6

  3. La terapia combinada puede ser tan efectiva como la terapia antirretroviral de alta eficacia en el control de la carga viral en niños con un sistema inmunitario conservado

    Acta Pediatrica Espanola, Vol. 64, Núm. 8, pp. 377-382

  4. Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency

    Pediatric Infectious Disease Journal, Vol. 25, Núm. 4, pp. 365-368

2004

  1. The effects on infants of potent antiretroviral therapy during pregnancy: A report from Spain

    Medical Science Monitor, Vol. 10, Núm. 5

2003

  1. Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational Study

    Clinical Infectious Diseases, Vol. 37, Núm. 9, pp. 1216-1225

2002

  1. Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments

    Acta Paediatrica, International Journal of Paediatrics, Vol. 91, Núm. 7, pp. 776-782

  2. Impact of antiretroviral protocols on dynamics of AIDS progression markers

    Archives of Disease in Childhood, Vol. 86, Núm. 2, pp. 119-124

  3. Respuesta al tratamiento antirretroviral en niños infectados verticalmente por el virus de la inmunodeficiencia humana tipo 1

    Medicina Clinica, Vol. 119, Núm. 19, pp. 725-729